MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/liv.16204

Медицинская библиотека · Liver international : official journal of the International Association for the Study of the Liver · 2025

Metabolomic Changes Associated With the Change in HVPG After DAAs Therapy in HCV Cirrhotic Patients.

Virseda-Berdices Ana, Martín-Escolano Rubén, Berenguer Juan, González-García Juan, Brochado-Kith Oscar, Rojo David, Díez Cristina, Hontañon Víctor, Pérez-Latorre Leire, Ibañez-Samaniego Luis, Llop-Herrera Elba, Olveira Antonio, Fernández-Rodríguez Amanda, Barbas Coral, Resino Salvador, Jiménez-Sousa María Ángeles, ESCORIAL Study Group

СтатьяМногоцентровое исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND AND AIMS: In response to direct-acting antivirals (DAAs) therapy, patients who experience a decrease in hepatic venous pressure gradient (HVPG) considerably reduce liver complications and have increased survival. This study aimed to assess the metabolomic changes associated with the changes in HVPG from the start of DAA therapy until 48 weeks after effective DAA therapy in patients with advanced HCV-related cirrhosis.

METHODS

We carried out a multicenter longitudinal study in 31 patients with advanced hepatitis C virus (HCV)-related cirrhosis. We performed a non-targeted metabolomic analysis using gas chromatography-mass spectrometry and liquid chromatography-mass spectrometry, as well as analysis of inflammation-related biomarkers using Luminex technology. The statistical analysis was performed by Generalised Linear Mixed-effects Models (GLMM), correcting for multiple testing.

RESULTS

We found that increases of 2,3-butanediol (AMR = 1.15; q-value = 0.023) and taurocholic acid (AMR = 1.06; q-value < 0.001) were significantly associated with increases in HVPG and inflammatory biomarker levels from before DAA therapy to one year after completion of successful HCV treatment.

CONCLUSIONS

These metabolites have a potential role as indicators of portal hypertension evolution.

Для цитирования: Virseda-Berdices Ana, Martín-Escolano Rubén, Berenguer Juan, González-García Juan, Brochado-Kith Oscar, Rojo David, Díez Cristina, Hontañon Víctor, Pérez-Latorre Leire, Ibañez-Samaniego Luis, Llop-Herrera Elba, Olveira Antonio, Fernández-Rodríguez Amanda, Barbas Coral, Resino Salvador, Jiménez-Sousa María Ángeles, ESCORIAL Study Group. Metabolomic Changes Associated With the Change in HVPG After DAAs Therapy in HCV Cirrhotic Patients.. Liver international : official journal of the International Association for the Study of the Liver. 2025. DOI: 10.1111/liv.16204.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.